The United States International Trade Commission (USITC) released its highly anticipated report,“COVID-19 Diagnostics and Therapeutics, Supply, Demand, and TRIPS Agreement Flexibilities” on October 17. Evidence presented in the 496-page report…
Cary Vance, President and CEO of Titan Medical, joined AdvaMed®’s Scott Whitaker on the Medtech POV podcast to share his experience leading a small medical device company through the regulatory…
This white paper from IQVIA – an associate member of AdvaMed® – discusses how global markets and specific therapeutic areas are poised for growth over the next decade.
This report outlines a key data-driven summary of the U.S. COVID testing supply.
Mick Farrell, CEO of ResMed, joined Scott Whitaker on the Medtech POV podcast to explain what motivates him to serve patients and his community.
Mick Farrell, ResMed CEO and member of the AdvaMed® board of directors, joined AdvaMed®’s Scott Whitaker on the Medtech POV podcast to discuss how an agile company with skilled staff…
This report examines cumulative data from the first two years of the COVID Test Registry to demonstrate the mobilization of the diagnostics industry over the course of the pandemic.
Today, AdvaMed® President and CEO Scott Whitaker issued a statement following the White House’s announcement that the federal government’s COVID-19 response would be reduced in the coming weeks without additional…
This evening, President Joe Biden addressed the nation on the state of the union, including our national response to the COVID-19 pandemic and his Cancer Moonshot initiative.
The Advanced Medical Technology Association® (AdvaMed®), working in the United Kingdom with the Medical Technology Group (MTG) and the Association of British HealthTech Industries (ABHI), commends the recent announcement by the UK Government of aggressive polices to address…